Published in Nat Rev Immunol on October 01, 2012
Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera. Nat Commun (2015) 1.22
Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG. PLoS Genet (2013) 1.21
Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev (2014) 1.17
Altered fecal microbiota composition associated with food allergy in infants. Appl Environ Microbiol (2014) 1.11
Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis (2015) 1.09
Host adaptive immunity alters gut microbiota. ISME J (2014) 1.06
Dynamics of gut microbiota in autoimmune lupus. Appl Environ Microbiol (2014) 0.99
Timely approaches to identify probiotic species of the genus Lactobacillus. Gut Pathog (2013) 0.95
Genome instability in Lactobacillus rhamnosus GG. Appl Environ Microbiol (2013) 0.89
VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep (2013) 0.87
Intestinal barrier: A gentlemen's agreement between microbiota and immunity. World J Gastrointest Pathophysiol (2014) 0.87
Diet complexity and estrogen receptor β status affect the composition of the murine intestinal microbiota. Appl Environ Microbiol (2013) 0.87
Gut microbiota as potential therapeutic target for the treatment of cow's milk allergy. Nutrients (2013) 0.85
Taxonomic Identification of Ruminal Epithelial Bacterial Diversity during Rumen Development in Goats. Appl Environ Microbiol (2015) 0.82
Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms. Antonie Van Leeuwenhoek (2014) 0.82
Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? J Pathol (2014) 0.82
Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS One (2014) 0.80
Food derived bioactive peptides and intestinal barrier function. Int J Mol Sci (2014) 0.80
Are vaccination models suitable to determine whether probiotics have beneficial health effects in the general population? Hum Vaccin Immunother (2013) 0.80
Luminal Conversion and Immunoregulation by Probiotics. Front Pharmacol (2015) 0.79
Functional genomic analyses of the gut microbiota for CRC screening. Nat Rev Gastroenterol Hepatol (2013) 0.78
Probiotics in the treatment of chronic rhinoconjunctivitis and chronic rhinosinusitis. J Allergy (Cairo) (2014) 0.78
Sterile post-traumatic immunosuppression. Clin Transl Immunology (2016) 0.77
Transcriptomic Profile of Whole Blood Cells from Elderly Subjects Fed Probiotic Bacteria Lactobacillus rhamnosus GG ATCC 53103 (LGG) in a Phase I Open Label Study. PLoS One (2016) 0.77
Enhanced Mucosal Antibody Production and Protection against Respiratory Infections Following an Orally Administered Bacterial Extract. Front Med (Lausanne) (2014) 0.76
Immunostimulatory Effects Triggered by Enterococcus faecalis CECT7121 Probiotic Strain Involve Activation of Dendritic Cells and Interferon-Gamma Production. PLoS One (2015) 0.76
Probiotics and blood pressure: current insights. Integr Blood Press Control (2016) 0.75
Extraction of Peptidoglycan from L. paracasei subp. Paracasei X12 and Its Preliminary Mechanisms of Inducing Immunogenic Cell Death in HT-29 Cells. Int J Mol Sci (2015) 0.75
Changes in Metabolically Active Bacterial Community during Rumen Development, and Their Alteration by Rhubarb Root Powder Revealed by 16S rRNA Amplicon Sequencing. Front Microbiol (2017) 0.75
β2→1-Fructans Modulate the Immune System In Vivo in a Microbiota-Dependent and -Independent Fashion. Front Immunol (2017) 0.75
Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr (2017) 0.75
Administration of immunobiotic Lactobacillus plantarum delays but does not prevent lethal pneumovirus infection in Rag1(-/-) mice. J Leukoc Biol (2017) 0.75
Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial Applications. Front Microbiol (2017) 0.75
The Postpartum Maternal and Newborn Microbiomes. MCN Am J Matern Child Nurs (2017) 0.75
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Linking long-term dietary patterns with gut microbial enterotypes. Science (2011) 17.30
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
Concern Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 10.70
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet (2001) 6.82
Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 5.83
Homeostasis and inflammation in the intestine. Cell (2010) 4.60
Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol (2002) 3.79
Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol (2010) 3.45
Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A (2011) 3.19
Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc Natl Acad Sci U S A (2005) 2.82
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol (2007) 2.77
S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A (2008) 2.65
T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res (2009) 2.43
The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol (2006) 2.31
Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A (2009) 2.29
Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol (2010) 2.22
Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest (2011) 2.16
Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol (2011) 2.15
Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther (2008) 2.13
Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A (2012) 2.09
Predictive biomarkers: a paradigm shift towards personalized cancer medicine. Nat Rev Clin Oncol (2011) 2.02
Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut (2012) 2.02
A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child (2006) 1.94
Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol (1994) 1.90
Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol (2010) 1.89
A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One (2012) 1.86
The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol (2011) 1.86
The extracellular biology of the lactobacilli. FEMS Microbiol Rev (2010) 1.84
Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial. Br J Dermatol (2010) 1.83
The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J (2012) 1.81
Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol (2009) 1.80
Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clin Exp Allergy (2008) 1.79
Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr (2011) 1.67
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One (2009) 1.60
Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A (2010) 1.56
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2007) 1.55
Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol (2006) 1.52
Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics (2008) 1.51
In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci U S A (2010) 1.47
The significant role of mast cells in cancer. Cancer Metastasis Rev (2011) 1.42
A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2008) 1.35
The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy (2009) 1.34
Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol (2011) 1.31
The inflammatory status of old age can be nurtured from the intestinal environment. Curr Opin Clin Nutr Metab Care (2008) 1.31
Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine. Microb Biotechnol (2010) 1.30
Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A (2012) 1.30
Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe (2012) 1.28
Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS One (2011) 1.21
Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis (2010) 1.13
Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial. Allergy (2010) 1.12
Probiotic supplementation in the first 6 months of life in at risk Asian infants--effects on eczema and atopic sensitization at the age of 1 year. Clin Exp Allergy (2008) 1.11
Probiotics during weaning reduce the incidence of eczema. Pediatr Allergy Immunol (2009) 1.10
A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Br J Nutr (2011) 1.10
Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol (2009) 1.09
Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology (2012) 1.08
The major secreted protein Msp1/p75 is O-glycosylated in Lactobacillus rhamnosus GG. Microb Cell Fact (2012) 1.06
Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants. J Allergy Clin Immunol (2010) 1.03
Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. Am J Clin Nutr (2008) 1.02
A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterol (2010) 1.01
Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev (2011) 1.00
Probiotics for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2008) 0.97
Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol (2010) 0.96
A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit (2011) 0.95
Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates. Clin Exp Allergy (2007) 0.94
Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study. Clin Gastroenterol Hepatol (2005) 0.88
Anti-inflammatory potential of probiotics: lipoteichoic acid makes a difference. Trends Microbiol (2011) 0.87
Lessons from probiotic-host interaction studies in murine models of experimental colitis. Mol Nutr Food Res (2011) 0.85
Efficacy of probiotics for the management of inflammatory bowel disease. Gastroenterol Hepatol (N Y) (2011) 0.77
Enterotypes of the human gut microbiome. Nature (2011) 24.36
Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93
Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity (2007) 4.87
Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol (2005) 4.86
Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J Exp Med (2006) 4.53
The biology of intestinal immunoglobulin A responses. Immunity (2008) 3.18
10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol (2005) 2.80
New insights in the molecular biology and physiology of Streptococcus thermophilus revealed by comparative genomics. FEMS Microbiol Rev (2005) 2.58
Bacteria-induced gap junctions in tumors favor antigen cross-presentation and antitumor immunity. Sci Transl Med (2010) 2.32
Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc Natl Acad Sci U S A (2009) 2.29
Phenotypic and genomic diversity of Lactobacillus plantarum strains isolated from various environmental niches. Environ Microbiol (2009) 2.18
Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol (2011) 2.15
Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol (2006) 2.14
Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J Bacteriol (2004) 2.06
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J Exp Med (2011) 2.06
Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut (2012) 2.02
Exploring Lactobacillus plantarum genome diversity by using microarrays. J Bacteriol (2005) 2.02
Discovering lactic acid bacteria by genomics. Antonie Van Leeuwenhoek (2002) 1.90
Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J Bacteriol (2005) 1.85
The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J (2012) 1.81
Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol (2011) 1.76
Genome-wide detection and analysis of cell wall-bound proteins with LPxTG-like sorting motifs. J Bacteriol (2005) 1.75
Isolation of RNA from bacterial samples of the human gastrointestinal tract. Nat Protoc (2006) 1.75
Complete resequencing and reannotation of the Lactobacillus plantarum WCFS1 genome. J Bacteriol (2012) 1.71
Cre-lox-based system for multiple gene deletions and selectable-marker removal in Lactobacillus plantarum. Appl Environ Microbiol (2006) 1.70
Complete sequences of four plasmids of Lactococcus lactis subsp. cremoris SK11 reveal extensive adaptation to the dairy environment. Appl Environ Microbiol (2005) 1.69
Lactobacillus plantarum gene clusters encoding putative cell-surface protein complexes for carbohydrate utilization are conserved in specific gram-positive bacteria. BMC Genomics (2006) 1.65
Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology (2008) 1.62
An agr-like two-component regulatory system in Lactobacillus plantarum is involved in production of a novel cyclic peptide and regulation of adherence. J Bacteriol (2005) 1.61
Cell to cell communication by autoinducing peptides in gram-positive bacteria. Antonie Van Leeuwenhoek (2002) 1.61
Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol (2010) 1.60
Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One (2009) 1.60
High temporal and inter-individual variation detected in the human ileal microbiota. Environ Microbiol (2010) 1.59
Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization. PLoS One (2010) 1.56
Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A (2010) 1.56
Entry route of Salmonella typhimurium directs the type of induced immune response. Immunity (2007) 1.53
Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. BMC Microbiol (2010) 1.51
Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different. Blood (2005) 1.50
Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. Blood (2013) 1.49
Isolation of DNA from bacterial samples of the human gastrointestinal tract. Nat Protoc (2006) 1.43
Comparative analysis of proteins with a mucus-binding domain found exclusively in lactic acid bacteria. Microbiology (2006) 1.42
Microbial domestication signatures of Lactococcus lactis can be reproduced by experimental evolution. Genome Res (2011) 1.41
Metabolic engineering of lactic acid bacteria, the combined approach: kinetic modelling, metabolic control and experimental analysis. Microbiology (2002) 1.40
Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo. J Exp Med (2003) 1.39
TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J (2010) 1.37
Increased production of folate by metabolic engineering of Lactococcus lactis. Appl Environ Microbiol (2003) 1.37
Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunol (2012) 1.36
Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol (2004) 1.36
Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J (2012) 1.34
Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J (2012) 1.33
Convergence in probiotic Lactobacillus gut-adaptive responses in humans and mice. ISME J (2010) 1.33
Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol (2013) 1.31
Spatial and temporal expression of Lactobacillus plantarum genes in the gastrointestinal tracts of mice. Appl Environ Microbiol (2006) 1.31
The complete genomes of Lactobacillus plantarum and Lactobacillus johnsonii reveal extensive differences in chromosome organization and gene content. Microbiology (2004) 1.31
Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats. Environ Microbiol (2011) 1.31
Multifactorial diversity sustains microbial community stability. ISME J (2013) 1.29
Cancer immunotherapy based on killing of Salmonella-infected tumor cells. Cancer Res (2005) 1.28
The prophage sequences of Lactobacillus plantarum strain WCFS1. Virology (2003) 1.28
Characterization and functional analysis of the poxB gene, which encodes pyruvate oxidase in Lactobacillus plantarum. J Bacteriol (2004) 1.27
Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol (2012) 1.23
Mucosal dendritic cells in immunity and inflammation. Nat Immunol (2004) 1.22
Effect of different NADH oxidase levels on glucose metabolism by Lactococcus lactis: kinetics of intracellular metabolite pools determined by in vivo nuclear magnetic resonance. Appl Environ Microbiol (2002) 1.21
Regulation of the metC-cysK operon, involved in sulfur metabolism in Lactococcus lactis. J Bacteriol (2002) 1.21
IS981-mediated adaptive evolution recovers lactate production by ldhB transcription activation in a lactate dehydrogenase-deficient strain of Lactococcus lactis. J Bacteriol (2003) 1.20
Genome data mining of lactic acid bacteria: the impact of bioinformatics. Curr Opin Biotechnol (2004) 1.19
Development and characterization of a subtilin-regulated expression system in Bacillus subtilis: strict control of gene expression by addition of subtilin. Appl Environ Microbiol (2005) 1.19
Major role of NAD-dependent lactate dehydrogenases in aerobic lactate utilization in Lactobacillus plantarum during early stationary phase. J Bacteriol (2004) 1.18
Use of the alr gene as a food-grade selection marker in lactic acid bacteria. Appl Environ Microbiol (2002) 1.18
Metatranscriptome analysis of the human fecal microbiota reveals subject-specific expression profiles, with genes encoding proteins involved in carbohydrate metabolism being dominantly expressed. Appl Environ Microbiol (2010) 1.18
The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J Exp Med (2007) 1.16
Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Appl Environ Microbiol (2010) 1.15
Lifestyle of Lactobacillus plantarum in the mouse caecum. Environ Microbiol (2009) 1.15
A comprehensive metatranscriptome analysis pipeline and its validation using human small intestine microbiota datasets. BMC Genomics (2013) 1.15
Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol (2012) 1.15
Lactate racemization as a rescue pathway for supplying D-lactate to the cell wall biosynthesis machinery in Lactobacillus plantarum. J Bacteriol (2005) 1.14
The predicted secretome of Lactobacillus plantarum WCFS1 sheds light on interactions with its environment. Microbiology (2006) 1.14
Predicting cis-acting elements of Lactobacillus plantarum by comparative genomics with different taxonomic subgroups. Nucleic Acids Res (2006) 1.12
Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo. BMC Genomics (2008) 1.12
Diversity of human small intestinal Streptococcus and Veillonella populations. FEMS Microbiol Ecol (2013) 1.12
Potential and opportunities for use of recombinant lactic acid bacteria in human health. Adv Appl Microbiol (2004) 1.11
An in silico analysis of T-box regulated genes and T-box evolution in prokaryotes, with emphasis on prediction of substrate specificity of transporters. BMC Genomics (2008) 1.11
Metabolic engineering of lactic acid bacteria for the production of nutraceuticals. Antonie Van Leeuwenhoek (2002) 1.09
The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells. J Exp Med (2009) 1.08
Microbial communities in the human small intestine: coupling diversity to metagenomics. Future Microbiol (2007) 1.07
Recombinant lactic acid bacteria as mucosal biotherapeutic agents. Trends Biotechnol (2011) 1.05
Short- and long-term adaptation to ethanol stress and its cross-protective consequences in Lactobacillus plantarum. Appl Environ Microbiol (2011) 1.04
Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice. J Cell Sci (2005) 1.04
D-alanyl ester depletion of teichoic acids in Lactobacillus plantarum results in a major modification of lipoteichoic acid composition and cell wall perforations at the septum mediated by the Acm2 autolysin. J Bacteriol (2006) 1.02
sigma54-Mediated control of the mannose phosphotransferase sytem in Lactobacillus plantarum impacts on carbohydrate metabolism. Microbiology (2009) 1.02
The quest for probiotic effector molecules--unraveling strain specificity at the molecular level. Pharmacol Res (2012) 1.02
Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol (2008) 1.00
Fluorescence and atomic force microscopy imaging of wall teichoic acids in Lactobacillus plantarum. ACS Chem Biol (2011) 1.00
Functional analysis of three plasmids from Lactobacillus plantarum. Appl Environ Microbiol (2005) 0.99
Gut bacteria-host metabolic interplay during conventionalisation of the mouse germfree colon. ISME J (2012) 0.99
Genome sequence of the naturally plasmid-free Lactobacillus plantarum strain NC8 (CCUG 61730). J Bacteriol (2012) 0.98
Regulatory phenotyping reveals important diversity within the species Lactococcus lactis. Appl Environ Microbiol (2009) 0.97
Involvement of pyruvate oxidase activity and acetate production in the survival of Lactobacillus plantarum during the stationary phase of aerobic growth. Appl Environ Microbiol (2006) 0.97
Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis (2006) 0.97